Undisclosed Analgesic Program

About Epiodyne

Epiodyne is an early-stage biotech tackling the opioid crisis through a novel approach to opioid pharmacology. The company aims to engineer small-molecule opioids that retain potent analgesic properties while minimizing the risks of addiction, misuse, and respiratory depression that characterize current opioids. Operating in a high-need but challenging regulatory and scientific environment, Epiodyne represents a new wave of companies seeking to rehabilitate the opioid class for therapeutic use. As a private, pre-clinical company, its success hinges on validating its platform and advancing candidates into clinical development.

Therapeutic Areas